000 | 01552 a2200445 4500 | ||
---|---|---|---|
005 | 20250515084146.0 | ||
264 | 0 | _c20071127 | |
008 | 200711s 0 0 eng d | ||
022 | _a1464-4096 | ||
024 | 7 |
_a10.1111/j.1464-410X.2007.07095.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlbouy, Baptiste | |
245 | 0 | 0 |
_aPreliminary results of the Prostacox phase II trial in hormonal refractory prostate cancer. _h[electronic resource] |
260 |
_bBJU international _cOct 2007 |
||
300 |
_a770-4 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aCelecoxib |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTourani, Jean-Marc | |
700 | 1 | _aAllain, Patrick | |
700 | 1 | _aRolland, Frederic | |
700 | 1 | _aStaerman, Frederic | |
700 | 1 | _aEschwege, Pascal | |
700 | 1 | _aPfister, Christian | |
773 | 0 |
_tBJU international _gvol. 100 _gno. 4 _gp. 770-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1464-410X.2007.07095.x _zAvailable from publisher's website |
999 |
_c17350938 _d17350938 |